438 related articles for article (PubMed ID: 22515800)
1. Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: results of a single-arm uncontrolled study with 1-year follow-up.
Rabago D; Zgierska A; Fortney L; Kijowski R; Mundt M; Ryan M; Grettie J; Patterson JJ
J Altern Complement Med; 2012 Apr; 18(4):408-14. PubMed ID: 22515800
[TBL] [Abstract][Full Text] [Related]
2. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial.
Rabago D; Patterson JJ; Mundt M; Kijowski R; Grettie J; Segal NA; Zgierska A
Ann Fam Med; 2013; 11(3):229-37. PubMed ID: 23690322
[TBL] [Abstract][Full Text] [Related]
3. Dextrose and morrhuate sodium injections (prolotherapy) for knee osteoarthritis: a prospective open-label trial.
Rabago D; Patterson JJ; Mundt M; Zgierska A; Fortney L; Grettie J; Kijowski R
J Altern Complement Med; 2014 May; 20(5):383-91. PubMed ID: 24635447
[TBL] [Abstract][Full Text] [Related]
4. Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis.
Rabago D; Kijowski R; Woods M; Patterson JJ; Mundt M; Zgierska A; Grettie J; Lyftogt J; Fortney L
Arch Phys Med Rehabil; 2013 Nov; 94(11):2075-82. PubMed ID: 23850615
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intra-articular hypertonic dextrose prolotherapy versus normal saline for knee osteoarthritis: a protocol for a triple-blinded randomized controlled trial.
Sit RWS; Wu RWK; Reeves KD; Rabago D; Chan DCC; Yip BHK; Chung VCH; Wong SYS
BMC Complement Altern Med; 2018 May; 18(1):157. PubMed ID: 29764447
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Dextrose Prolotherapy in Symptomatic Knee Osteoarthritis: A Randomized Controlled Study.
Sert AT; Sen EI; Esmaeilzadeh S; Ozcan E
J Altern Complement Med; 2020 May; 26(5):409-417. PubMed ID: 32223554
[No Abstract] [Full Text] [Related]
7. Efficacy of Intra-Articular Hypertonic Dextrose (Prolotherapy) for Knee Osteoarthritis: A Randomized Controlled Trial.
Sit RWS; Wu RWK; Rabago D; Reeves KD; Chan DCC; Yip BHK; Chung VCH; Wong SYS
Ann Fam Med; 2020 May; 18(3):235-242. PubMed ID: 32393559
[TBL] [Abstract][Full Text] [Related]
8. Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis: Feasibility, Acceptability, and Patient-Oriented Outcomes in a Pilot-Level Quality Improvement Project.
Rabago D; Kansariwala I; Marshall D; Nourani B; Stiffler-Joachim M; Heiderscheit B
J Altern Complement Med; 2019 Apr; 25(4):406-412. PubMed ID: 30688517
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: Long term outcomes.
Rabago D; Mundt M; Zgierska A; Grettie J
Complement Ther Med; 2015 Jun; 23(3):388-95. PubMed ID: 26051574
[TBL] [Abstract][Full Text] [Related]
10. Chondrogenic Effect of Intra-articular Hypertonic-Dextrose (Prolotherapy) in Severe Knee Osteoarthritis.
Topol GA; Podesta LA; Reeves KD; Giraldo MM; Johnson LL; Grasso R; Jamín A; Clark T; Rabago D
PM R; 2016 Nov; 8(11):1072-1082. PubMed ID: 27058744
[TBL] [Abstract][Full Text] [Related]
11. Qualitative Assessment of Patients Receiving Prolotherapy for Knee Osteoarthritis in a Multimethod Study.
Rabago D; van Leuven L; Benes L; Fortney L; Slattengren A; Grettie J; Mundt M
J Altern Complement Med; 2016 Dec; 22(12):983-989. PubMed ID: 27603001
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up.
Eslamian F; Amouzandeh B
Ther Adv Musculoskelet Dis; 2015 Apr; 7(2):35-44. PubMed ID: 25829954
[TBL] [Abstract][Full Text] [Related]
13. Demonstrating the effectiveness of intra-articular prolotherapy combined with peri-articular perineural injection in knee osteoarthritis: a randomized controlled trial.
Fu Y; Du Y; Li J; Xi Y; Ji W; Li T
J Orthop Surg Res; 2024 May; 19(1):279. PubMed ID: 38705988
[TBL] [Abstract][Full Text] [Related]
14. Effect of regenerative injection therapy on function and pain in patients with knee osteoarthritis: a randomized crossover study.
Dumais R; Benoit C; Dumais A; Babin L; Bordage R; de Arcos C; Allard J; Bélanger M
Pain Med; 2012 Aug; 13(8):990-9. PubMed ID: 22759069
[TBL] [Abstract][Full Text] [Related]
15. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity.
Reeves KD; Hassanein K
Altern Ther Health Med; 2000 Mar; 6(2):68-74, 77-80. PubMed ID: 10710805
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis.
Chu J; Duan W; Yu Z; Tao T; Xu J; Ma Q; Zhao L; Guo JJ
Knee Surg Sports Traumatol Arthrosc; 2022 Dec; 30(12):4063-4071. PubMed ID: 35124707
[TBL] [Abstract][Full Text] [Related]
17. Effects of Intra-articular Coinjections of Hyaluronic Acid and Hypertonic Dextrose on Knee Osteoarthritis: A Prospective, Randomized, Double-Blind Trial.
Hsieh RL; Lee WC
Arch Phys Med Rehabil; 2022 Aug; 103(8):1505-1514. PubMed ID: 35439521
[TBL] [Abstract][Full Text] [Related]
18. Changes in levels of cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial.
Waluyo Y; Budu ; Bukhari A; Adnan E; Haryadi RD; Idris I; Hamid F; Usman A; Johan MP; Zainuddin AA
J Rehabil Med; 2021 May; 53(5):jrm00196. PubMed ID: 33904585
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: A randomized clinical trial.
Farpour HR; Fereydooni F
Electron Physician; 2017 Nov; 9(11):5663-5669. PubMed ID: 29403602
[TBL] [Abstract][Full Text] [Related]
20. Identification of early response to hypertonic dextrose prolotherapy markers in knee osteoarthritis patients by an inflammation-related cytokine array.
Pan PJ; Wang JC; Tsai CC; Kuo HC
J Chin Med Assoc; 2022 Apr; 85(4):525-531. PubMed ID: 35019866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
